Evidence map›Paper›PMID 40269188›Full record

ArticleMolecular psychiatry2025

Estradiol, via estrogen receptor β signaling, mediates stress-susceptibility in the male brain.

Polymnia Georgiou, Abagail F Postle, Ta-Chung M Mou, Liam E Potter, Xiaoxian An, Panos Zanos, Michael S Patton, Katherine J Pultorak, Sarah M Clark, Vien Ngyuyen and 8 more

Abstract read
In one paragraph

Article in Molecular psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Polymnia GeorgiouVeterans Affairs Maryland Health Care System, Baltimore, MD, 21201, USA. georgiop@uwm.edu.ORCID http://orcid.org/0000-0003-3171-9993
Abagail F PostleDepartment of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.
Ta-Chung M MouDepartment of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.
Liam E PotterDepartment of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.
Xiaoxian AnDepartment of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.
Panos ZanosDepartment of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-1968-8648
Michael S PattonDepartment of Pharmacology and Physiology, University of Maryland School of Medicine, Baltimore, MD, USA.
Katherine J PultorakDepartment of Pharmacology and Physiology, University of Maryland School of Medicine, Baltimore, MD, USA.
Sarah M ClarkVeterans Affairs Maryland Health Care System, Baltimore, MD, 21201, USA.ORCID http://orcid.org/0000-0001-7328-0726
Vien NgyuyenDepartment of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, TX, 76107, USA.
Chris F PowelsVeterans Affairs Maryland Health Care System, Baltimore, MD, 21201, USA.
Katalin Prokai-TatraiDepartment of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, TX, 76107, USA.
Antonis KirmizisDepartment of Biological Sciences, University of Cyprus, Nicosia, Cyprus.
Istvan MerchenthalerDepartment of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Laszlo ProkaiDepartment of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, TX, 76107, USA.
Margaret M McCarthyDepartment of Pharmacology and Physiology, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0003-2243-4726
Brian N MathurDepartment of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0003-2912-8625
Todd D GouldVeterans Affairs Maryland Health Care System, Baltimore, MD, 21201, USA. tgould@som.umaryland.edu.ORCID http://orcid.org/0000-0003-1511-7183

Funding

Role of Brain Estradiol in the Treatment of Male Depression and AnxietyR21MH100700 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI GOULD, TODD D, PROKAI, LASZLO · 2013 to 2014
$429k
BLRD VA I01 BX006018EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 Marie Skłodowska-Curie Actions (H2020 Excellent Science - Marie Skłodowska-Curie Actions) 101031317Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.) NIH R21-MH100700NIMH NIH HHS R21 MH100700U.S. Department of Veterans Affairs (Department of Veterans Affairs) 1I01BX006018
6 · The paper itself

Abstract

Dysregulation of normal reward processing via psychological stress contributes to the development of psychiatric disorders. Estrogen is involved in reward processing in females, but this effect has not been well studied in males despite the abundant conversion of androgens to estrogens in the male brain. Here, we used a combination of genetic deletions, behavioral assays, pharmacology, circuit dissection, electrophysiology, in vivo fiber photometry, and optogenetics/chemogenetics to determine the role of the most prevalent and potent estrogen, 17β-estradiol, in male stress-induced reward processing dysfunction. We found that absence of estrogen receptor (ER) β renders male but not female mice susceptible to stress-induced maladaptive reward-processing behaviors. We demonstrated that activation of ERβ-projecting neurons from the basolateral amygdala to nucleus accumbens induced rewarding effects in male, but not female mice. Moreover, we show that the activity of ERβ-expressing neurons projecting from the basolateral amygdala to nucleus accumbens is reduced in hypogonadal male mice subjected to stress, while activation of this circuit reverses stress-induced maladaptive reward processing behaviors and inhibition induces stress susceptibility. We identified that absence of estradiol, but not testosterone per se, underlies susceptibility to stress-mediated dysfunction of rewarding behaviors and that brain-selective delivery of estradiol and intra-basolateral amygdala administration of an ERβ-specific agonist prevent maladaptive reward-processing behaviors in hypogonadal male mice. These findings delineate an estrogen-based mechanism underlying stress susceptibility and provide a novel therapeutic strategy for the treatment of reward-related disorders associated with hypogonadal conditions.

Indexed as

EstradiolEstrogen Receptor betaStress, PsychologicalAmygdalaAnimalsBasolateral Nuclear ComplexBrainEstrogensFemaleMaleMiceMice, Inbred C57BLMice, KnockoutNeuronsNucleus AccumbensRewardEstradiolEstrogen Receptor betaEstrogens

Identifiers

PMID40269188
PMCPMC12235942

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.